Article info
Basic and translational research
Concise report
Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis
- Correspondence to Dr Peter LEM van Lent, Experimental Rheumatology, Department of Rheumatology, Radboud University Medical Center, Geert Grooteplein 28, PO Box 9101, Nijmegen 6500 HB, The Netherlands; Peter.vanLent{at}radboudumc.nl
Citation
Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis
Publication history
- Received August 21, 2014
- Revised April 24, 2015
- Accepted April 26, 2015
- First published May 12, 2015.
Online issue publication
June 09, 2023
Article Versions
- Previous version (9 June 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/